TY - JOUR
T1 - Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer l,2-dithiole-3-thione
AU - Kensler, Thomas W.
AU - Groopman, John D.
AU - Eaton, David L.
AU - Curphey, Thomas J.
AU - Roebuck, B. D.
N1 - Funding Information:
We thank Patrick Dolan, Patricia Egner, Theresa Giles, Denise MacMillan and Kirk van Ness for excellent technical assistance and Karen Baumgartner for the statistical analyses. This work was supported by grants from the American Cancer Society (SIG-3) and the National Institutes of Health (CA39416, CA47561). T.W.K. and J.D.G. are recipients of N1H Research Career Development Awards CAO123O and CA01517, respectively.
PY - 1992/1
Y1 - 1992/1
N2 - l,2-Dithiole-3-thiones are five-membered cyclic sulfur-containing compounds with antioxidant, chemotherapeutic, radioprotective and chemoprotective properties. Several substituted l,2-dithiole-3-thiones are used medicinally and one of these, oltipraz [5-(2-pyrazinyl)-4-methyl-l,2-dithiole-3-thione], has been recently shown to be an inhibitor of aflatoxin B1 (AFB1) hepatocarcinogenesis in the rat. Structure-activity studies have been undertaken to probe the mechanisms by which dithiolethiones inhibit carcinogenesis. Such studies revealed that unsubstituted l,2-dithiole-3-thione was more effective than oltipraz at inhibiting aflatoxin-DNA adduct formation in vivo and at inducing electrophile detoxication enzymes in cell culture. In the present studies the effects of dietary administration of l,2-dithiole-3-thione on the induction of xenobiotic metabolizing enzymes and inhibition of aflatoxin-induced hepatic tumorigenesis were examined. Male F344 rats were fed graded doses of 1,2-dithiole-3-thione (0.001-0.03%) for 4 weeks. During the second and third weeks of l,2-dithiole-3-thione feeding, rats were dosed by gavage with 250μg of AFB1/kg five times a week. Rats were then restored to control AIN-76A diet 1 week after cessation of AFB1 dosing. At 4 months, focal areas of hepatocellular alteration were identified and quantified by staining sections of liver for λ-glutamyltranspeptidase (GGT) activity and glutathione S-transferase P (GST-P) expression. Treatment with l,2-dithiole-3-thione at the lowest dose (0.001%) reduced by >80% the volume of liver occupied by GGT or GST-P foci; higher dietary concentrations provided > 98% reductions in the volume per cent of these markers for presumptive preneoplastic lesions. All dietary concentrations of l,2-dithiole-3-thione resulted in significant elevations in hepatic GST activities. In accord with the protective effects against tumorigenesis, 4- to 6-fold increases in the specific activities of aflatoxin-glutathione conjugation were observed in cytosols prepared from livers of animals fed 1,2-dithiole-3-thione. By contrast, l,2-dithiole-3-thione did not have any detectable inductive effects on hepatic mkrosomal cytochrome P450 levels or activities. Dietary administration of 1,2-di-thiole-3-thione also elevated activities of GSTs and other phase II enzymes in several extrahepatic organs. This broad pattern of induction of detoxication enzymes by 1,2-dithiole-3-thione supports the potential widespread use of this compound as a protective agent against chemical carcino-genesis and other forms of electrophile toxicity.
AB - l,2-Dithiole-3-thiones are five-membered cyclic sulfur-containing compounds with antioxidant, chemotherapeutic, radioprotective and chemoprotective properties. Several substituted l,2-dithiole-3-thiones are used medicinally and one of these, oltipraz [5-(2-pyrazinyl)-4-methyl-l,2-dithiole-3-thione], has been recently shown to be an inhibitor of aflatoxin B1 (AFB1) hepatocarcinogenesis in the rat. Structure-activity studies have been undertaken to probe the mechanisms by which dithiolethiones inhibit carcinogenesis. Such studies revealed that unsubstituted l,2-dithiole-3-thione was more effective than oltipraz at inhibiting aflatoxin-DNA adduct formation in vivo and at inducing electrophile detoxication enzymes in cell culture. In the present studies the effects of dietary administration of l,2-dithiole-3-thione on the induction of xenobiotic metabolizing enzymes and inhibition of aflatoxin-induced hepatic tumorigenesis were examined. Male F344 rats were fed graded doses of 1,2-dithiole-3-thione (0.001-0.03%) for 4 weeks. During the second and third weeks of l,2-dithiole-3-thione feeding, rats were dosed by gavage with 250μg of AFB1/kg five times a week. Rats were then restored to control AIN-76A diet 1 week after cessation of AFB1 dosing. At 4 months, focal areas of hepatocellular alteration were identified and quantified by staining sections of liver for λ-glutamyltranspeptidase (GGT) activity and glutathione S-transferase P (GST-P) expression. Treatment with l,2-dithiole-3-thione at the lowest dose (0.001%) reduced by >80% the volume of liver occupied by GGT or GST-P foci; higher dietary concentrations provided > 98% reductions in the volume per cent of these markers for presumptive preneoplastic lesions. All dietary concentrations of l,2-dithiole-3-thione resulted in significant elevations in hepatic GST activities. In accord with the protective effects against tumorigenesis, 4- to 6-fold increases in the specific activities of aflatoxin-glutathione conjugation were observed in cytosols prepared from livers of animals fed 1,2-dithiole-3-thione. By contrast, l,2-dithiole-3-thione did not have any detectable inductive effects on hepatic mkrosomal cytochrome P450 levels or activities. Dietary administration of 1,2-di-thiole-3-thione also elevated activities of GSTs and other phase II enzymes in several extrahepatic organs. This broad pattern of induction of detoxication enzymes by 1,2-dithiole-3-thione supports the potential widespread use of this compound as a protective agent against chemical carcino-genesis and other forms of electrophile toxicity.
UR - http://www.scopus.com/inward/record.url?scp=0026501721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026501721&partnerID=8YFLogxK
U2 - 10.1093/carcin/13.1.95
DO - 10.1093/carcin/13.1.95
M3 - Article
C2 - 1346373
AN - SCOPUS:0026501721
SN - 0143-3334
VL - 13
SP - 95
EP - 100
JO - Carcinogenesis
JF - Carcinogenesis
IS - 1
ER -